122 related articles for article (PubMed ID: 11178963)
21. Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.
Masson E; Wiernsperger N; Lagarde M; El Bawab S
Glycobiology; 2005 Jun; 15(6):585-91. PubMed ID: 15625180
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
[TBL] [Abstract][Full Text] [Related]
23. Lipid and ganglioside alterations in tumor cells treated with antimitotic oleyl glycoside.
García-Álvarez I; Egido-Gabás M; Romero-Ramírez L; Doncel-Pérez E; Nieto-Sampedro M; Casas J; Fernández-Mayoralas A
Mol Biosyst; 2011 Jan; 7(1):129-38. PubMed ID: 21057675
[TBL] [Abstract][Full Text] [Related]
24. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
27. [The effects of caspase-3 in apoptosis of cultured retinal microvascular pericytes induced by advanced glycation end products].
Chen BH; Jiang DY; Tang LS
Zhonghua Yan Ke Za Zhi; 2007 May; 43(5):393-6. PubMed ID: 17706085
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
29. Microvascular basement membranes in diabetes mellitus.
Tsilibary EC
J Pathol; 2003 Jul; 200(4):537-46. PubMed ID: 12845621
[TBL] [Abstract][Full Text] [Related]
30. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
Rojas A; Morales MA
Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
[TBL] [Abstract][Full Text] [Related]
32. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.
Hao M; Li SY; Sun CK; Jingyu-Xu ; Lin Y; Liu KX; Wang L; Li CX; Zhou Q; Du JL; Li H
Eur J Pharmacol; 2011 Mar; 654(3):320-5. PubMed ID: 21236251
[TBL] [Abstract][Full Text] [Related]
33. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
[TBL] [Abstract][Full Text] [Related]
34. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
35. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
[TBL] [Abstract][Full Text] [Related]
36. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.
Chen Q; Dong L; Wang L; Kang L; Xu B
Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321
[TBL] [Abstract][Full Text] [Related]
37. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
38. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
39. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
[TBL] [Abstract][Full Text] [Related]
40. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
Yamagishi S; Matsui T; Nakamura K; Inoue H
Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]